甲状腺功能与阿尔茨海默病风险:一项孟德尔随机化研究
该研究采用孟德尔随机化方法,利用ThyroidOmics联盟(最多119,715人)和阿尔茨海默病全基因组关联研究(最多71,880例)的汇总数据,检验遗传预测的甲状腺功能正常范围内变异及甲状腺功能减退与阿尔茨海默病风险的因果关系。结果显示,遗传预测的正常范围内促甲状腺激素水平升高与阿尔茨海默病风险降低相关(p=0.02),在50岁以下人群中亦相关(p=0.04);游离甲状腺素(p=0.54)、全范围促甲状腺激素(p=0.06)及甲状腺功能减退(p=0.23)均无证据支持因果关联。双向孟德尔随机化未显示阿尔茨海默病遗传易感性对促甲状腺激素或游离甲状腺素水平有影响。
要点
- 遗传预测的正常范围内促甲状腺激素升高与阿尔茨海默病风险降低相关(p=0.02)。
- 50岁以下人群中,正常范围内促甲状腺激素每升高1个标准差与阿尔茨海默病风险降低相关(p=0.04)。
- 游离甲状腺素、全范围促甲状腺激素及甲状腺功能减退与阿尔茨海默病无因果关联证据。
核心结论
- 遗传预测的正常范围内促甲状腺激素水平升高及较年轻人群中的促甲状腺激素升高与阿尔茨海默病风险降低相关。
- 遗传预测的全范围促甲状腺激素与阿尔茨海默病风险呈边缘性关联。
- 无证据表明遗传预测的游离甲状腺素或甲状腺功能减退对阿尔茨海默病有影响。
- 未来研究应阐明潜在的病理生理机制。
研究设计与样本
- 采用孟德尔随机化分析,使用与正常范围促甲状腺激素和游离甲状腺素水平相关的遗传工具。
- 次要分析包括探究甲状腺功能减退的作用,并进行了双向孟德尔随机化以探讨潜在的反向因果关联。
- 汇总统计来自ThyroidOmics联盟(最多119,715人)和最新阿尔茨海默病全基因组关联研究数据(最多71,880例)。
主要发现
- 孟德尔随机化分析显示遗传预测的正常范围促甲状腺激素水平升高与阿尔茨海默病风险降低相关(p=0.02)。
- 在50岁以下个体中,正常范围促甲状腺激素水平每升高1个标准差与阿尔茨海默病风险降低相关(p=0.04)。
- 无证据表明游离甲状腺素与阿尔茨海默病存在因果关联(p=0.54)。
- 未发现遗传预测的全范围促甲状腺激素水平(p=0.06)或甲状腺功能减退(p=0.23)与阿尔茨海默病存在效应。
- 双向孟德尔随机化未显示阿尔茨海默病遗传易感性对促甲状腺激素或游离甲状腺素水平有任何效应。
局限性
- 未来研究应阐明潜在的病理生理机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Observational studies suggest an association between thyroid function and risk of dementia, but the causality and direction of these effects are unclear. We aim to test whether genetically predicted variation within the normal range of thyroid function and hypothyroidism is causally associated with the risk of Alzheimer's disease (AD). Methods: Mendelian randomization (MR) analyses using genetic instruments are associated with normal range thyrotropin (TSH) and free thyroxine (fT4) levels. Secondary analyses included investigation of the role of hypothyroidism. Bidirectional MR was conducted to address the presence of a potential reverse causal association. Summary statistics were obtained from the ThyroidOmics Consortium involving up to 119,715 individuals and the latest AD genome-wide association study data including up to 71,880 cases. Results: MR analyses show an association between increased genetically predicted normal range TSH levels and a decreased risk of AD (p = 0.02). One standard deviation increased normal range TSH levels were associated with a decreased risk of AD in individuals younger than 50 years old (p = 0.04). There was no evidence for a causal association between fT4 (p = 0.54) and AD. We did not identify any effect of the genetically predicted full range TSH levels (p = 0.06) or hypothyroidism (p = 0.23) with AD. Bidirectional MR did not show any effect of genetic predisposition to AD on TSH or fT4 levels. Conclusions: This MR study shows that increased levels of genetically predicted TSH within the normal range and in younger individuals are associated with a decreased risk of AD. We observed a marginal association between genetically predicted full range TSH and AD risk. There was no evidence for an effect between genetically predicted fT4 or hypothyroidism on AD. Future studies should clarify the underlying pathophysiological mechanisms.
引用
- Marouli E, Yusuf L, Kjaergaard AD, et al. Thyroid Function and the Risk of Alzheimer's Disease: A Mendelian Randomization Study. Thyroid. 2021. PMID: 34847795. doi:10.1089/thy.2021.0321
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。